Aligos Therapeutics
0 followers
‌
Aligos Therapeutics is discovering and developing new classes of compounds that interact directly with disease causing molecules.
Industries
Headquarters
Employees
Links
Org chart
Lawrence M. Blatt
Chairman & CEO
Lawrence M. Blatt
Collapse
Lesley Ann Calhoun
EVP & CFO
Lucinda Y. Quan
EVP, Chief Business Officer & General Counsel
Julian A. Symons
EVP & Chief Scientific Officer
Dave Smith
Executive Vice President
Tse-I Lin
VP, Early Compound Development & Belgian Site Head
Kristina Engeseth
VP & Head, People & Culture
Dinah Misner
Vice President
